Assenagon Asset Management S.A. Zai Lab LTD Transaction History

Assenagon Asset Management S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$105.0 - $178.37 $1.85 Million - $3.15 Million	-17,652 Closed	0 $0
Q2 2021 Jul 15, 2021	SELL	$125.11 - $180.0 $3.87 Million - $5.57 Million	-30,964 Reduced 63.69%	17,652 $3.12 Million
Q1 2021 Apr 26, 2021	SELL	$126.27 - $191.71 $17.8 Million - $27 Million	-140,722 Reduced 74.32%	48,616 $6.49 Million
Q4 2020 Feb 01, 2021	SELL	$81.94 - $135.34 $4.32 Million - $7.13 Million	-52,710 Reduced 21.78%	189,338 $25.6 Million
Q3 2020 Oct 07, 2020	SELL	$73.3 - $89.48 $10.2 Million - $12.4 Million	-138,529 Reduced 36.4%	242,048 $20.1 Million
Q2 2020 Jul 21, 2020	BUY	$48.82 - $82.53 $8.12 Million - $13.7 Million	166,256 Added 77.57%	380,577 $31.3 Million
Q1 2020 Apr 17, 2020	BUY	$39.1 - $62.9 $8.38 Million - $13.5 Million	214,321 New	214,321 $11 Million
Q3 2019 Oct 16, 2019	SELL	$30.47 - $37.65 $770,891 - $952,545	-25,300 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$25.73 - $35.79 $650,969 - $905,487	25,300 New	25,300 $882,000

147

46.4M

103K

439K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.18B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.